ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

18.33
0.70
(3.97%)
Closed April 26 4:00PM
18.9321
0.6021
(3.28%)
After Hours: 5:30PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
18.9321
Bid
17.25
Ask
21.50
Volume
1,323,140
17.29 Day's Range 18.45
5.12 52 Week Range 25.29
Market Cap
Previous Close
17.63
Open
17.29
Last Trade
14
@
18.5
Last Trade Time
Financial Volume
$ 23,961,801
VWAP
18.1098
Average Volume (3m)
1,816,686
Shares Outstanding
88,739,826
Dividend Yield
-
PE Ratio
-5.06
Earnings Per Share (EPS)
-3.62
Revenue
233.18M
Net Profit
-321.55M

About Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Lewes, Delaware, USA
Founded
-
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was $17.63. Over the last year, Travere Therapeutics shares have traded in a share price range of $ 5.12 to $ 25.29.

Travere Therapeutics currently has 88,739,826 shares outstanding. The market capitalization of Travere Therapeutics is $1.56 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -5.06.

Travere Therapeutics (TVTX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-39k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

TVTX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.202128.527494908414.7318.932114.71137543716.41882607CS
4-1.4979-7.3318649045520.4320.6612.9186287015.73484591CS
12-2.2579-10.655497876421.1925.2912.9181668619.32478259CS
260.74214.0797141286418.1925.2912.9153617718.91382099CS
5213.7021261.9904397715.2325.295.12149846215.0183225CS
156-8.5079-31.005466472327.4429.145.12130431715.19390404CS
260-6.2179-24.723260437425.1533.08995.12112317616.86290719CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is $ 18.9321
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 88,739,826 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1.56B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of $ 5.12 to $ 25.29 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -5.06
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 6.98
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 233.18M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -321.55M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WWWW International Inc
$ 0.395
(167.62%)
223.58M
OMEXOdyssey Marine Exploration Inc
$ 1.4979
(75.79%)
285.65M
RTCBaijiayun Group Ltd
$ 0.3244
(74.88%)
263.23M
GREEGreenidge Generation Holdings Inc
$ 1.3197
(53.92%)
5.84M
SXTCChina SXT Pharmaceuticals Inc
$ 2.28
(44.30%)
38.04M
CGTLCreative Global Technology Holdings Ltd
$ 1.5197
(-75.09%)
3.88M
TOIIWOncology Institute Inc
$ 0.1015
(-40.22%)
156.14k
COEPCoeptis Therapeutics Holdings Inc
$ 7.70
(-38.25%)
716.99k
INTSIntesity Therapeutics Inc
$ 0.56
(-37.78%)
3.21M
SMMTSummit Therapeutics Inc
$ 23.47
(-36.05%)
24.67M
GNLNGreenlane Holdings Inc
$ 0.012699
(-15.34%)
355.22M
AGMHAGM Group Holdings Inc
$ 0.0477
(22.31%)
340.91M
OMEXOdyssey Marine Exploration Inc
$ 1.4979
(75.79%)
285.65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 10.455
(19.62%)
266.95M
RTCBaijiayun Group Ltd
$ 0.3244
(74.88%)
263.23M

Your Recent History

Delayed Upgrade Clock